There are growing signs an unprecedented exodus of life scientists from academia is slowing the pace of basic research -- untested hypotheses, unused grant dollars & projects languishing in limbo.
My special report for @statnews
https://t.co/fTQcTwbfhP
Chimeras are fantastical creatures composed of different body parts. Now, modern biology holds that humans can also be chimeras, housing cells from different genetic origins. My latest for @statnews.
Kristine Chua's work has the potential to help reinvent how scientists define the human body and open new paths for improving maternal health. Here's her story: https://t.co/nIKl8AkOtU
Excited to share my first video for @NIHBrainTumor, chronicling the important work of @LarionMioara! Her @NCIResearchCtr lab explores the metabolic needs of cancer cells, in order to develop targeted approaches that delay brain tumor growth. Full video: https://t.co/KKpoy6S9Yd
Today I can finally say I've finished my PhD. I want to get a lot of things off my chest and @PhDVoice might be the right place for it. So here is the story of my PhD and my advice to people who are considering doing one.
Check out today’s special print issue on the brain in the @washingtonpost Health+Science section!
I wrote about a fascinating link between inflammation of the body and depression in the brain:
https://t.co/6DYSvAbRYa
Biogen knew Aduhelm would dramatically affect Medicare. If just 250,000 patients got the drug, it would account for more than 25% of the Part B budget. If Aduhelm reached its full potential, it would cost taxpayers upward of $70 billion.